On June 16, Senate Finance Committee Democrats released an RFI on proposals to lower the cost of prescription drugs. On Aug. 17, AMCP submitted comments in response.
AMCP Comment Letter on Transparency in Coverage
AMCP supports The Departments’ goal of improving transparency in coverage but urges the agency to finalize a rule that emphasizes usability, standardization, and alignment with existing regulatory frameworks. Transparency policies should enhance, not hinder, managed care pharmacy efforts to control costs and improve access, while ensuring consumers have useful, relevant information.
Related
On June 5, the New York State Assembly passed S.5939C/A.5882C, commonly referred to as the Patient Access to Pharmacy Act (PAPA), sending the pharmacy benefit manager (PBM) reimbursement legislation to Governor Kathy Hochul for consideration. The Senate previously passed the measure on May 28.
Featured News & Resources
See Full Calendar
Other Events
AMCP Florida-Puerto Rico Day of Education 2026
Other Events
AMCP Georgia Day of Education 2026
Upcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
